With more than 60 years of peptide manufacturing experience, Aspen API continues to build on its established expertise while exploring opportunities in the oligonucleotide space. Participation in forums such as TIDES reflects our commitment to innovation, collaboration, and long-term value creation in an evolving pharmaceutical landscape.